STOCK TITAN

Rigel to Present at the Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Rigel Pharmaceuticals will present a company overview at the Jefferies 2023 London Healthcare Conference on November 14, 2023. The presentation will be given by Dean Schorno, the company's CFO, at 3:30 p.m. GMT. The webcast can be accessed on Rigel's website.
Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Nov. 6, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Jefferies 2023 London Healthcare Conference on Tuesday, November 14, 2023 at 3:30 p.m. GMT (10:30 a.m. EST).

To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Investors & Media Contacts:  
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com 

Media:
David Rosen 
Argot Partners 
Phone: 212.600.1902
Email: david.rosen@argotpartners.com 

Rigel Pharmaceuticals Logo (PRNewsfoto/Rigel Pharmaceuticals, Inc.)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-jefferies-london-healthcare-conference-301978009.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

What is the Jefferies 2023 London Healthcare Conference?

The Jefferies 2023 London Healthcare Conference is an event where healthcare companies present their company overviews.

Who will be presenting at the conference?

Dean Schorno, the CFO of Rigel Pharmaceuticals, will be presenting at the conference.

When will the presentation take place?

The presentation will take place on November 14, 2023, at 3:30 p.m. GMT.

Where can I access the webcast?

The webcast can be accessed on Rigel Pharmaceuticals' website in the Investor Relations section.

Is the webcast available for viewing after the live presentation?

Yes, an archived recording of the webcast will be available on Rigel Pharmaceuticals' website.

What should I do before the live webcast?

It is recommended to connect to Rigel Pharmaceuticals' website prior to the start of the live webcast to allow for any necessary software downloads.

Rigel Pharmaceuticals Inc. (New)

NASDAQ:RIGL

RIGL Rankings

RIGL Latest News

RIGL Stock Data

210.49M
146.96M
2.11%
61.38%
2.86%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
SOUTH SAN FRANCISCO

About RIGL

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.